Blood Pressure-Lowering Medications (Antihypertensives): High doses of NAD supplements might reduce blood pressure, which, combined with antihypertensive drugs, could cause blood pressure to drop too low (hypotension)
Yet, in the three-plus decades since BPC-157 was discovered, no controlled human trial of the peptide has ever been published
45%, 32%, and 23% of patients had Hurley stages I, II, and III disease, respectively
Actual DSIP funds disbursed since 2013 have failed to meet their budgeted targets
Additional safety considerations include pancreatitis risk, gallbladder disease, potential for acute kidney injury with dehydration, and possible worsening of diabetic retinopathy with rapid glycemic improvement